Edimer Pharmaceuticals

Edimer Pharmaceuticals is engaged in research and development for treatments of rare dermatological diseases, including X-linked Hypohidrotic Ectodermal Dysplasia (XLHED). XLHED is a rare orphan disease that causes a range of symptoms including lack of sweat glands, poor temperature control, respiratory problems, and hair and tooth malformations. The company is based in Cambridge, Massachusetts.